Anti-Dementia Drugs for Psychopathology and Cognitive Impairment in Schizophrenia: A Systematic Review and Meta-Analysis

BACKGROUND: We conducted a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials of anti-dementia drugs plus antipsychotics for schizophrenia. METHODS: Primary outcomes of efficacy and safety included improving overall symptoms (Positive and Negative Syndrome Sca...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Neuropsychopharmacol
Autors principals: Kishi, Taro, Ikuta, Toshikazu, Oya, Kazuto, Matsunaga, Shinji, Matsuda, Yuki, Iwata, Nakao
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6070030/
https://ncbi.nlm.nih.gov/pubmed/29762677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyy045
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars